Private Advisor Group, LLC Atossa Therapeutics, Inc. Transaction History

Private Advisor Group, LLC

  • $14.8 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 14, 2022
SELL
$0.82 - $1.14 $1,318 - $1,833
-1,608 Reduced 13.84%
10,013 $8,000
Q2 2022

Jul 13, 2022
BUY
$0.85 - $1.28 $212 - $320
250 Added 2.2%
11,621 $13,000
Q1 2022

May 12, 2022
BUY
$1.11 - $1.74 $184 - $288
166 Added 1.48%
11,371 $14,000
Q3 2021

Oct 14, 2021
BUY
$2.89 - $6.4 $32,382 - $71,712
11,205 New
11,205 $37,000

Others Institutions Holding ATOS

# of Institutions
81
Shares Held
25.8M
Call Options Held
404K
Put Options Held
83.6K
View Full List

About ATOSSA THERAPEUTICS, INC.

ATOS Quotes by TradingView
  • Ticker ATOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 126,624,000
  • Market Cap $192M
  • Description
  • Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing A...
More about ATOS
Track This Portfolio

Track Private Advisor Group, LLC Portfolio

Follow Private Advisor Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Advisor Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email